Regular psychosocial intervention combined with antipsychotic drugs, compared with usual medication alone treatments, can reduce psychiatric symptoms and improve quality of life in patients with schizophrenia. However, it's expensive, time-consuming, and sometimes inconvenient for patients and their family members in developing areas where the number of well-trained therapist remains limited in local psychiatric settings. The investigators aimed to establish an efficient model of integrated treatment (IT) for patients with schizophrenia. The procedure contains two stages: a centralized treatment during hospitalization and the following consolidation treatments with long intervals.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
170
All patients with schizophrenia were under medication treatment at the baseline. Individualized plan of antipsychotic medication for the patients were determined by psychiatrist who were blind to the group allocation. Medications could be changed at any time during the course of the study if the change was clinically warranted, the drug can also be any other antipsychotic medication.
Patients with schizophrenia allocated to the Integrated Treatment(IT) group received Cognitive behavioral therapy.
Rehabilitation treatment include three modules: medication management, symptom management, and social kill training. Patients with schizophrenia allocated to the Integrated Treatment(IT) group received Rehabilitation treatment therapy.
Patients with schizophrenia allocated to the Integrated Treatment(IT) group received Case management.
Guangzhou psychitric hosptial
Guangzhou, Guangdong, China
RECRUITINGMedication nonadherence was assessed in two groups after 12-month follow-up.
Medication non-adherence was defined as a failure to take medication for one week or longer
Time frame: One year follow-up
Rehospitalization rate was assessed in two groups after 12-month follow-up.
Time frame: One year follow-up
Rate of Relapse was assessed in two groups after 12-month follow-up.
Time frame: One year follow-up
Improvement of symptoms in each group was assessed by the change of PANSS(Positive and Negative Syndrome Scale) total scale score.
Time course and treatment differences for changes in the PANSS( Positive and Negative Syndrome Scale) was analyzed using Mixed-Effects Model for Repeated-Measures analyses (MMRM).
Time frame: One year follow-up
Improvement of symptoms in each group was assessed by the change of CGI( Clinical Global Impressions) scale score.
Time course and treatment differences for changes in the CGI( Clinical Global Impressions) was analyzed using Mixed-Effects Model for Repeated-Measures analyses (MMRM).
Time frame: One year follow-up
Social functioning in each group was assessed by the change of PSP(Personal and Social Performance)scale score.
Time course and treatment differences for changes in the PSP(Personal and Social Performance) were analyzed using Mixed-Effects Model for Repeated-Measures analyses (MMRM).
Time frame: One year follow-up
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.